Flibanserin: A Viagra Equivalent Developed For Women

 

The sexual functions of a man and women defers significantly, with the man being able to achieve an erection that causes a physical change in his reproductive organ, which is not present among women. This is also one of the main reasons why a larger emphasis is usually placed on sexual dysfunctions affecting men, when compared to sexual dysfunctions that affect women. When a man experiences a sexual dysfunction, he often finds it difficult to have healthy, firm and lasting erections that offer pleasure to both him and his partner. The process that is involved in a man’s sexual response is also considered more physical than a women’s sexual response, which is considered to involve a larger amount of psychological factors than physiological factors.

These facts do not, however, mean that women are at any lower risk of developing a sexual dysfunction than a man. In fact, according to data released by MedScape, as much as 63% of the female population suffers from symptoms of female sexual dysfunction. They report that up to 32% of women have problems with their libido, which causes them to become less interested in being involved in sexual activities. As much as 28% of women are unable to have an orgasm, while up to 21% of women experience pain while having sexual intercourse and an estimated amount of 27% do not find sex pleasurable. When you compare this to the data released by a study regarding sexual dysfunctions among men, it becomes clear that women may be at a higher risk when it comes to problems with their sexual lives.

Causes of Female Sexual Dysfunctions

Unlike male sexual dysfunctions that are commonly caused by issues with the blood circulation system in the body, female sexual dysfunctions are usually caused by other types of sources such as psychological factors, hormone imbalances and certain medical conditions. Mayo Clinic reports that these factors may include:

Female Sexual Dysfunctions
  • Physical medical conditions such as cancer, bladder problems, multiple sclerosis and kidney failure.
  • Medication used to treat certain health conditions, including high blood pressure, depression and allergic responses by the body.
  • A lack of healthy estrogen levels in the female body.
  • Depression or anxiety that goes untreated, especially when the source of these psychological disorders come from a past relationship that was abusive.

Flibanserin

Flibanserin is a female sexual enhancement that is described to be an equivalent to Viagra and Cialis, but only for women instead of men. The product has been developed by a company known as Addyi and is the very first treatment meant to relief hypoactive sexual desire disorder amongst women to be approved by the Food and Drug Association. Flibanserin has been released with the primary function of treating sexual disorders among women who are experiencing premenopausal symptoms.

Addyi explains that they developed Flibanserin in order to treat hypoactive sexual desire disorder among women who are experiencing problems with their sexual desire. They continue to explain that this product has not been designed to treat sexual desire issues caused by medical, mental or relationship problems, nor has it been designed to counteract the impact certain medications may have on a woman’s sexual desire. Furthermore, they also explain that Flibanserin is meant to treat a loss of sexual desire in women who have not yet entered their menopausal years, but rather in women who are experiencing symptoms of perimenopause. Apart from these statements, Addyi explains that their FDA-approved sexual desire treatment has been developed for women and is not an effective treatment for men, does not improve a women’s sexual performance and should never be taken by children.

Addy Info

The FDA have officially approved the use of Addyi’s Flibanserin as a sexual desire disorder treatment for premenopausal women on 18 August 2015. They do report that, even though the drug has been approved by the administration, it is important to realize that the drug can only be obtained through a professional health care provided or pharmacy that has been officially certified to carry this new product from Addyi. Apart from this fact, it is vital for women who are interested in using this product to understand the risks involved. The FDA reported in their approval statement that this product has been associated with side-effects such as severe hypotension (low blood pressure), as well as syncope (loss of consciousness). Furthermore, tests have concluded that the product is also not safe to be taken with alcoholic drinks as alcohol increases the risk of developing one or more of the side-effects that have been associated with the use of the product. The product should also not be taken with CYP3A4 inhibiting medication as it can interfere with these medications and possibly cause adverse events to occur.

Conclusion

While male sexual dysfunctions are often a cause for concern, many fail to realize that the prevalence of sexual dysfunctions are higher among women than among men. Addyi’s target this problem at its course as the very first drug of its kind to be approved by the FDA. Even though the drug has been proven to provide benefits to premenopausal women, patients are advised by the FDA to carefully consider the side-effects and to discuss the use of the product with a doctor before taking a dose.

References

  • http://www.medscape.com/viewarticle/705592_4
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426773/
  • http://www.mayoclinic.org/diseases-conditions/female-sexual-dysfunction/basics/causes/con-20027721
  • http://www.addyi.com
  • http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm458734.htm

Take Action: Support Consumer Health Digest by linking to this article from your website

Permalink to this article:

Embed article link: (Click to copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite ConsumerHealthDigest.com with clickable link.



 
 
Author

Expert Author : Dr. Ahmed Zayed (Consumer Health Digest)

Dr. Ahmed Zayed Helmy holds a baccalaureate of Medicine and Surgery. He has completed his degree in 2011 at the University of Alexandria, Egypt. Dr. Ahmed believes in providing knowledgeable information to readers. Other than his passion for writing, currently he is working as a Plastic surgeon and is doing his masters at Ain shams University.